Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms
Launched by UNIVERSITY OF SAO PAULO GENERAL HOSPITAL · Jan 23, 2015
Trial Information
Current as of April 28, 2025
Unknown status
Keywords
ClinConnect Summary
Minimally Invasive Neurosurgery is a inexorable tendency and it is already a reality in many centers of the world. It is a broad and relative concept and there is few consistent medical data to validate its benefits. In this manner, this is the first clinical trial in Brazil questioning the safety of the of minimally invasive surgery to treat incidental cerebral aneurysms of the anterior circulation. For countries like Brazil, the indirect demonstration of reduction in hospital costs through lower hospital stays is a breakthrough to provide better health for the entire population.
Patients...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with the diagnosis of incidental unruptured cerebral aneurysms (4mm to 2cm)
- Exclusion Criteria:
- • Patients who do not have adequate family care during the immediate post-operative period (the patient's family must commit to stay with the patient in the first five days after hospital discharge)
- • Patients who are unable to communicate by telephone
- • People with cardiovascular disease, liver or kidney failure.
- • Pregnant women or breastfeeding
- • Patients with coagulation abnormalities
- • Patients with High Surgical Risk evaluated by different risk scores (ASA, AHA, Goldman, Detsky)
About University Of Sao Paulo General Hospital
The University of São Paulo General Hospital (Hospital das Clínicas da Universidade de São Paulo) is a leading clinical research institution in Brazil, renowned for its commitment to advancing medical knowledge and patient care. As an academic hospital affiliated with one of the largest and most prestigious universities in Latin America, it integrates clinical practice, education, and research. The hospital conducts a wide array of clinical trials across various medical disciplines, aiming to develop innovative therapies and improve healthcare outcomes. With a multidisciplinary team of healthcare professionals and access to cutting-edge facilities, the University of São Paulo General Hospital is dedicated to fostering scientific advancements and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Patients applied
Trial Officials
Eberval G Figueiredo, MD, PhD
Study Director
University of Sao Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials